Blue Light Blocking Glasses Show Early Promise as an Add-On Treatment for Mania
A small hospital trial found circadian interventions feasible during mania, with greater symptom improvement in groups using blue light blocking glasses.
Riepilogo
A small randomized study explored whether hospitalized patients with bipolar mania could follow two approaches aimed at supporting daily biological rhythms: blue light blocking glasses and a daytime eating window. Participants received glasses, a schedule of ten hours for eating followed by fourteen hours of fasting, or both, alongside usual treatment. Of twenty participants assessed for adherence, sixteen mostly followed their assigned approach or did better. Patients and staff generally supported the interventions, although some preferred more flexible schedules. Mania scores improved more in the groups using glasses than in the eating schedule alone group. However, this pilot primarily tested practicality, not treatment effectiveness. The abstract provides no numerical symptom differences or detailed safety results. These findings support further research, not replacing established psychiatric treatment.
Riepilogo Dettagliato
Sleep and disrupted daily rhythms are common in bipolar disorder and may complicate episodes of mania. Researchers tested whether hospitalized patients experiencing mania could follow two approaches intended to support biological timing: blue light blocking glasses and eating within a consistent daytime window. These were additions to usual treatment.
The randomized pilot trial assigned participants to glasses alone, time restricted eating alone, or both. The eating schedule allowed food during ten daytime hours, followed by fourteen hours of overnight fasting. Participants had clinically significant mania. Researchers primarily assessed adherence and interviewed patients and staff about practical barriers. Raters unaware of treatment assignment also measured changes in mania severity.
Twenty-one eligible participants consented. Among the twenty included in the reported adherence calculation, sixteen, or 80%, were mostly adherent or better. Adherence did not differ across groups. Interviews suggested patient interest and staff support, although some wanted shorter or more flexible schedules. Groups receiving glasses showed greater improvement in mania scores than the group following restricted eating alone.
These findings suggest that circadian interventions can be practical even during severe psychiatric illness in a supervised hospital setting. The glasses results offer an early signal worth testing in larger trials, rather than proof of benefit. The study does not establish whether combining glasses with restricted eating works better than glasses alone, or whether either approach improves longevity.
Important uncertainties remain. This was a small feasibility study, not a definitive treatment trial, and it lacked a usual care only comparison group. The abstract does not report treatment duration, numerical differences in mania scores, statistical uncertainty, or detailed safety findings. It also does not explain why adherence was reported for twenty rather than twenty-one participants. This summary is based on the abstract only. Patients should discuss these approaches with their psychiatric team before making changes.
Risultati Principali
- Sixteen of twenty assessed participants, or 80%, were mostly adherent or better; adherence did not differ across intervention groups.
- Groups using blue light blocking glasses showed greater improvement in mania scores than the group using time-restricted eating alone.
- The eating intervention used a ten-hour daytime eating window and fourteen-hour overnight fast.
- Patients and staff supported the approaches, but some wanted shorter or more flexible schedules.
- The pilot supports feasibility, not definitive effectiveness; these approaches were studied as additions to usual treatment.
Metodologia
This mixed methods randomized pilot assigned hospitalized patients with DSM-5 mania and Young Mania Rating Scale scores of at least 20 to three groups in a 1:1:1 ratio. Adherence and interviews assessed feasibility, while changes in mania scores assessed by blinded raters were a secondary outcome. The trial was registered as NCT06504342.
Limitazioni dello Studio
This summary is based on the abstract only, which does not provide intervention duration, numerical symptom effects, statistical uncertainty, or detailed safety findings. The small feasibility trial lacked a usual-care-only control and cannot establish effectiveness or generalizability outside supervised inpatient care. Twenty-one participants consented, but the abstract reports adherence for twenty without explaining the discrepancy.
Ti è piaciuto questo riepilogo?
Ricevi ogni settimana le ultime ricerche sulla longevità direttamente nella tua casella email.
Inserisci la tua email per iscriverti: